Posizioni attive di Emmanuelle Charpentier
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Fondatore | 01/01/2014 | - |
| Corporate Officer/Principal | 01/01/2014 | - |
Storia della carriera di Emmanuelle Charpentier
Precedenti posizioni note di Emmanuelle Charpentier
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CRISPR THERAPEUTICS AG | Fondatore | 31/10/2013 | - |
Statistiche
Distribuzione geografica
| Svizzera | 2 |
| Irlanda | 2 |
Posizioni
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Aziende private | 1 |
|---|---|
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Health Technology |
